Radboud University Nijmegen Medical Center — Nijmegen, Gelderland

Public research footprint of Radboud University Nijmegen Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cystinosis · Squamous Cell Carcinoma of the Head and Neck (SCCHN) · Glioblastoma With Oligodendroglial Component · Depressive Disorder, Major

Recently updated registry entries

NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)
NCT05333523 — Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and… (Recruiting)
NCT02442375 — Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Radboud University Nijmegen Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.